Patents by Inventor Ewa Cairns

Ewa Cairns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES ASSOCIATED WITH HLA-DR MHC CLASS II MOLECULE AND INVOLVED IN RHEUMATOID ARTHRITIS
    Publication number: 20170267740
    Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of rheumatoid arthritis.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Inventors: Jonathan Hill, Ewa Cairns, David Bell
  • Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseases
    Patent number: 9493539
    Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid arthritis.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: November 15, 2016
    Assignee: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventors: Jonathan Hill, Ewa Cairns, David Bell
  • PEPTIDES ASSOCIATED WITH HLA-DR MHC CLASS II MOLECULE AND INVOLVED IN RHEUMATOID ARTHRITIS
    Publication number: 20120225820
    Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of rheumatoid arthritis.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 6, 2012
    Applicant: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventors: Jonathan Hill, Ewa Cairns, David Bell
  • Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis
    Patent number: 8198401
    Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid Arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid Arthritis.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: June 12, 2012
    Assignee: London Health Sciences Centre Research Inc.
    Inventors: Jonathan Hill, Ewa Cairns, David Bell
  • Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis
    Publication number: 20090010943
    Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid Arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid Arthritis.
    Type: Application
    Filed: March 5, 2004
    Publication date: January 8, 2009
    Inventors: Jonathan Hill, Ewa Cairns, David Bell
  • Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases
    Publication number: 20070292347
    Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid arthritis.
    Type: Application
    Filed: March 5, 2004
    Publication date: December 20, 2007
    Inventors: Jonathan Hill, Ewa Cairns, David Bell